Cutaneous leishmaniasis: immune responses in protection and pathogenesis
Cutaneous leishmaniasis is a major public health problem and causes a range of diseases
from self-healing infections to chronic disfiguring disease. Currently, there is no vaccine for …
from self-healing infections to chronic disfiguring disease. Currently, there is no vaccine for …
Leishmaniasis in humans: drug or vaccine therapy?
M Ghorbani, R Farhoudi - Drug design, development and therapy, 2017 - Taylor & Francis
Leishmania is an obligate intracellular pathogen that invades phagocytic host cells.
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …
Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment
In global health, critical challenges have arisen from infectious diseases, including the
emergence and reemergence of old and new infectious diseases. Emergence and …
emergence and reemergence of old and new infectious diseases. Emergence and …
Possibilities and challenges for developing a successful vaccine for leishmaniasis
Leishmaniasis is a vector-borne disease caused by different species of protozoan parasites
of the genus Leishmania. It is a major health problem yet neglected tropical diseases, with …
of the genus Leishmania. It is a major health problem yet neglected tropical diseases, with …
Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection
ND Glennie, VA Yeramilli, DP Beiting… - Journal of Experimental …, 2015 - rupress.org
Leishmaniasis causes a significant disease burden worldwide. Although Leishmania-
infected patients become refractory to reinfection after disease resolution, effective immune …
infected patients become refractory to reinfection after disease resolution, effective immune …
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection
G Volpedo, RH Huston, EA Holcomb… - Expert review of …, 2021 - Taylor & Francis
Introduction Leishmaniasis is a major public health problem and the second most lethal
parasitic disease in the world due to the lack of effective treatments and vaccines. Even …
parasitic disease in the world due to the lack of effective treatments and vaccines. Even …
Leishmaniasis vaccine: where are we today?
L Kedzierski - Journal of global infectious diseases, 2010 - journals.lww.com
Leishmaniasis is a disease that ranges in severity from skin lesions to serious disfigurement
and fatal systemic infection. WHO has classified the disease as emerging and uncontrolled …
and fatal systemic infection. WHO has classified the disease as emerging and uncontrolled …
Neglected and endemic zoonoses
I Maudlin, MC Eisler… - … Transactions of the …, 2009 - royalsocietypublishing.org
Endemic zoonoses are found throughout the developing world, wherever people live in
close proximity to their animals, affecting not only the health of poor people but often also …
close proximity to their animals, affecting not only the health of poor people but often also …
Vaccine candidates for leishmaniasis: a review
R Nagill, S Kaur - International immunopharmacology, 2011 - Elsevier
Leishmaniasis is a diverse group of clinical syndromes caused by protozoan parasites of the
genus Leishmania. The clinical manifestation of the disease varies from self-limiting …
genus Leishmania. The clinical manifestation of the disease varies from self-limiting …
Immunological perspectives of leishmaniasis
S Nylén, S Gautam - Journal of global infectious diseases, 2010 - journals.lww.com
Leishmania parasites have been widely used in experimental models to understand
generation, maintenance and failure of immune responses underlying resistance and …
generation, maintenance and failure of immune responses underlying resistance and …